1. Home
  2. GDTC vs BEEM Comparison

GDTC vs BEEM Comparison

Compare GDTC & BEEM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GDTC
  • BEEM
  • Stock Information
  • Founded
  • GDTC 2018
  • BEEM 2006
  • Country
  • GDTC Singapore
  • BEEM United States
  • Employees
  • GDTC N/A
  • BEEM N/A
  • Industry
  • GDTC Biotechnology: Pharmaceutical Preparations
  • BEEM Semiconductors
  • Sector
  • GDTC Health Care
  • BEEM Technology
  • Exchange
  • GDTC Nasdaq
  • BEEM Nasdaq
  • Market Cap
  • GDTC 28.0M
  • BEEM 23.4M
  • IPO Year
  • GDTC 2023
  • BEEM N/A
  • Fundamental
  • Price
  • GDTC $2.27
  • BEEM $1.46
  • Analyst Decision
  • GDTC Buy
  • BEEM Strong Buy
  • Analyst Count
  • GDTC 1
  • BEEM 4
  • Target Price
  • GDTC $5.00
  • BEEM $5.33
  • AVG Volume (30 Days)
  • GDTC 6.5K
  • BEEM 1.2M
  • Earning Date
  • GDTC 01-01-0001
  • BEEM 08-12-2025
  • Dividend Yield
  • GDTC N/A
  • BEEM N/A
  • EPS Growth
  • GDTC N/A
  • BEEM N/A
  • EPS
  • GDTC N/A
  • BEEM N/A
  • Revenue
  • GDTC $368,838.00
  • BEEM $41,099,000.00
  • Revenue This Year
  • GDTC $5.37
  • BEEM N/A
  • Revenue Next Year
  • GDTC N/A
  • BEEM $38.51
  • P/E Ratio
  • GDTC N/A
  • BEEM N/A
  • Revenue Growth
  • GDTC N/A
  • BEEM N/A
  • 52 Week Low
  • GDTC $1.20
  • BEEM $1.33
  • 52 Week High
  • GDTC $4.05
  • BEEM $7.68
  • Technical
  • Relative Strength Index (RSI)
  • GDTC 54.58
  • BEEM 45.06
  • Support Level
  • GDTC $2.25
  • BEEM $1.39
  • Resistance Level
  • GDTC $2.35
  • BEEM $1.82
  • Average True Range (ATR)
  • GDTC 0.08
  • BEEM 0.11
  • MACD
  • GDTC 0.03
  • BEEM 0.01
  • Stochastic Oscillator
  • GDTC 85.29
  • BEEM 16.86

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

About BEEM Beam Global

Beam Global produces sustainable technology for electric vehicle (EV) charging, outdoor media, and energy security, without the construction, disruption, and costs of grid-tied solutions. Its products are founded upon its patented EV ARC and Solar Treelines and include BeamTrak patented solar tracking, and ARC Technology energy storage, along with EV charging, outdoor media, and disaster preparedness packages. From start to finish, the company develops, patents, designs, engineers, and manufactures renewably energized products that help the environment, empower communities, and keep people moving.

Share on Social Networks: